Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIAsp 30 vs BIAsp 30 + IAsp in Type 2 Diabetes
NCT01697631Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2002
- Primary completion
- Apr 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing BIAsp 30 Alone with BIAsp 30 + Insulin Aspart (2 arms). Primary endpoint: Glycosylated Haemoglobin. Started Jul 2002; status: completed.
02
Drugs
biphasic insulin aspartinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01697631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697631.